ArticleBiological procedures online

Two different point mutations in ABL gene ATP-binding domain conferring Primary Imatinib resistance in a Chronic Myeloid Leukemia (CML) patient: A case report.

Zafar Iqbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.